112 related articles for article (PubMed ID: 36179514)
1. Designing a vaccine-based therapy against Epstein-Barr virus-associated tumors using immunoinformatics approach.
Omoboyede V; Ibrahim O; Umar HI; Bello T; Adedeji AA; Khalid A; Fayojegbe ES; Ayomide AB; Chukwuemeka PO
Comput Biol Med; 2022 Nov; 150():106128. PubMed ID: 36179514
[TBL] [Abstract][Full Text] [Related]
2. Immunoinformatics Approach to Design Novel Subunit Vaccine against the Epstein-Barr Virus.
Moin AT; Patil RB; Tabassum T; Araf Y; Ullah MA; Snigdha HJ; Alam T; Alvey SA; Rudra B; Mina SA; Akter Y; Zhai J; Zheng C
Microbiol Spectr; 2022 Oct; 10(5):e0115122. PubMed ID: 36094198
[TBL] [Abstract][Full Text] [Related]
3. mRNA-Based Vaccine Designing against Epstein-Barr Virus to Induce an Immune Response Using Immunoinformatic and Molecular Modelling Approaches.
Althurwi HN; Alharthy KM; Albaqami FF; Altharawi A; Javed MR; Muhseen ZT; Tahir Ul Qamar M
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293632
[TBL] [Abstract][Full Text] [Related]
4. Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein-Barr virus-associated malignancy.
Ojha R; Nandani R; Prajapati VK
J Cell Physiol; 2019 May; 234(5):6437-6448. PubMed ID: 30362500
[TBL] [Abstract][Full Text] [Related]
5. Pan-genome and reverse vaccinology approaches to design multi-epitope vaccine against Epstein-Barr virus associated with colorectal cancer.
Priyamvada P; Ramaiah S
Immunol Res; 2023 Dec; 71(6):887-908. PubMed ID: 37423939
[TBL] [Abstract][Full Text] [Related]
6. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
Chand Y; Singh S
Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
[TBL] [Abstract][Full Text] [Related]
7. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
[TBL] [Abstract][Full Text] [Related]
8. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases.
Cui X; Snapper CM
Front Immunol; 2021; 12():734471. PubMed ID: 34691042
[TBL] [Abstract][Full Text] [Related]
9. Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches.
Rostamtabar M; Rahmani A; Baee M; Karkhah A; Prajapati VK; Ebrahimpour S; Nouri HR
Infect Genet Evol; 2019 Nov; 75():103992. PubMed ID: 31394292
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a multiepitope plasmid DNA encoding T and B lymphocyte epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a vaccine in mice.
Li W; Chen Q; Lin Q; Lv Y; Feng J; Liu J; Xu W; Chen S; Zhu X; Zhang L
Protein Pept Lett; 2013 Oct; 20(10):1136-43. PubMed ID: 23688153
[TBL] [Abstract][Full Text] [Related]
11. Immunoinformatics prediction of potential B-cell and T-cell epitopes as effective vaccine candidates for eliciting immunogenic responses against Epstein-Barr virus.
Olotu FA; Soliman MES
Biomed J; 2021 Jun; 44(3):317-337. PubMed ID: 34154948
[TBL] [Abstract][Full Text] [Related]
12. Employing an immunoinformatics approach revealed potent multi-epitope based subunit vaccine for lymphocytic choriomeningitis virus.
Waqas M; Aziz S; Bushra A; Halim SA; Ali A; Ullah S; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
J Infect Public Health; 2023 Feb; 16(2):214-232. PubMed ID: 36603375
[TBL] [Abstract][Full Text] [Related]
13. Design of a multi-epitopic vaccine against Epstein-Barr virus
Larijani A; Kia-Karimi A; Roostaei D
Front Immunol; 2023; 14():1115345. PubMed ID: 36999015
[TBL] [Abstract][Full Text] [Related]
14. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
15. Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection.
Kumar Pandey R; Ojha R; Mishra A; Kumar Prajapati V
J Cell Biochem; 2018 Sep; 119(9):7631-7642. PubMed ID: 29900580
[TBL] [Abstract][Full Text] [Related]
16. Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome.
Shahid F; Ashfaq UA; Javaid A; Khalid H
Infect Genet Evol; 2020 Jun; 80():104199. PubMed ID: 31962160
[TBL] [Abstract][Full Text] [Related]
17. Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection.
Narula A; Pandey RK; Khatoon N; Mishra A; Prajapati VK
Infect Genet Evol; 2018 Jul; 61():4-15. PubMed ID: 29535024
[TBL] [Abstract][Full Text] [Related]
18. Computational design of a potential multi-epitope subunit vaccine using immunoinformatics to fight Ebola virus.
Kadam A; Sasidharan S; Saudagar P
Infect Genet Evol; 2020 Nov; 85():104464. PubMed ID: 32681997
[TBL] [Abstract][Full Text] [Related]
19. Design of a multi-epitope-based vaccine consisted of immunodominant epitopes of structural proteins of SARS-CoV-2 using immunoinformatics approach.
Mahmoudvand S; Esmaeili Gouvarchin Ghaleh H; Jalilian FA; Farzanehpour M; Dorostkar R
Biotechnol Appl Biochem; 2023 Jun; 70(3):1189-1205. PubMed ID: 36577011
[TBL] [Abstract][Full Text] [Related]
20. In silico design and validation of a novel multi-epitope vaccine candidate against structural proteins of Chikungunya virus using comprehensive immunoinformatics analyses.
Mahmoodi S; Amirzakaria JZ; Ghasemian A
PLoS One; 2023; 18(5):e0285177. PubMed ID: 37146081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
